The bill could significantly impact state and federal health care policies regarding opioid prescription practices. By focusing on remote monitoring, it seeks to provide data that may lead to changes in how health care systems manage opioid prescriptions and patient follow-ups. The emphasis on identifying cohorts that may benefit from such monitoring suggests a targeted approach, improving care while potentially reducing costs associated with opioid treatment.
Summary
House Bill 4093, titled the Remote Opioid Monitoring Act of 2023, aims to investigate the effects of remote monitoring on individuals prescribed opioids. The bill mandates the Comptroller General of the United States to conduct a comprehensive study within 18 months of enactment. This study will assess the current state of remote monitoring practices associated with opioid prescriptions, comparing those with monitoring to those without, and evaluate the potential cost savings and health outcomes related to the intervention.
Contention
Notable points of contention around the bill may arise from varying opinions on the effectiveness of remote monitoring in opioid management. Concerns may include issues related to patient privacy and the feasibility of implementing widespread remote monitoring solutions in various healthcare settings. Additionally, stakeholders may debate the appropriate allocation of federal resources to support this monitoring initiative and the implications for both patients and providers in managing opioid treatments.
ACE Act End Zuckerbucks Act of 2023 Solving an Overlooked Loophole in Votes for Executives (SOLVE) Act Promoting Free and Fair Elections Act Don't Weaponize the IRS Act American Confidence in Elections Act